Technology | Clinical Decision Support | August 08, 2018

Aidoc Receives FDA Clearance for AI Detection of Acute Intracranial Hemorrhage

Workflow solution powered by artificial intelligence assists radiologists in workflow triage

Aidoc Receives FDA Clearance for AI Detection of Acute Intracranial Hemorrhage
The Influence of AI-Based Prioritization on RTAT

Image courtesy of Aidoc

August 8, 2018 — Aidoc announced that it was granted U.S. Food and Drug Administration (FDA) clearance for the first product of its expanding suite of artificial intelligence (AI)-based workflow optimization solutions. The clearance is for Aidoc’s brain solution that works with radiologists to flag acute intracranial hemorrhage (ICH) cases in head computed tomography (CT) scans. Aidoc calls it the world's first deep learning solution to assist radiologists in workflow triage.

With over 75 percent of all patient care involving radiology, the amount of imaging is skyrocketing while the number of radiologists is struggling to catch up. Radiologists are being pressured to produce quality results at a faster pace with increasing amounts of data — but with tools that are not up to the task, according to Aidoc. The company’s solution analyzes medical images directly after the patient is scanned and notifies the radiologist of cases with suspected findings to assist with prioritization of time-sensitive and potentially life-threatening cases.

“In a recent clinical study we ran, Aidoc’s brain package demonstrated its potential to substantially reduce report turnaround time and increase the radiologist’s confidence” said Barry D. Pressman, M.D., chairman of imaging at Cedars-Sinai Medical Center and former president of the American College of Radiology. “Seeing the software in action emphasized the key aspects an AI solution needs to possess to have an impact on the radiologist day to day — seamless integration into the workflow and broad applicability. With the evidence I’ve seen, in the not so distant future, it will almost be unthinkable to practice radiology without the assistance of solutions like Aidoc”

Already commercialized outside the U.S. since December 2017, Aidoc is in the process of FDA clearance for its full body coverage solutions which will assist in the detection of a broad set of acute pathologies.

For more information: www.aidoc.com

Related Content

These MRI scans show diffuse white matter abnormality (DWMA). The top three panels display raw MRI images from very preterm infants born at 27 weeks (left), 26 weeks (center) and 31 weeks (right) gestation.

These MRI scans show diffuse white matter abnormality (DWMA). The top three panels display raw MRI images from very preterm infants born at 27 weeks (left), 26 weeks (center) and 31 weeks (right) gestation. Higher signal intensity can be seen in the central white matter, particularly for the 31-week gestation infant. The bottom panels display the corresponding slices with objectively segmented DWMA in yellow. The 27-week infant (left) was diagnosed with mild DWMA, the 26-week infant (center) was diagnosed with moderate DWMA, and the 31-week infant had severe DWMA. Image courtesy of Cincinnati Children's and Nature Scientific Reports

News | Magnetic Resonance Imaging (MRI) | October 01, 2020
October 1, 2020 — As many as 70% of very premature infants (born earlier than 32 weeks gestation) show signs of white
Siemens Healthineers has introduced a new version of its c.cam dedicated cardiac nuclear medicine system to the U.S. market. This single-photon emission computed tomography (SPECT) scanner with a reclining patient chair offers nuclear cardiology providers a low total cost of ownership, ease of installation, and a high level of image quality.
News | SPECT Imaging | September 30, 2020
September 30, 2020 — Siemens Healthineers h
The artificial intelligence-driven Caption Guidance software guides point of care ultrasound (POCUS) users to get optimal cardiac ultrasound images. The AI software is an example of a FDA-cleared software that is helping improve imaging, even when used by less experienced users.

The artificial intelligence-driven Caption Guidance software guides point of care ultrasound (POCUS) users to get optimal cardiac ultrasound images. The AI software is an example of a FDA-cleared software that is helping improve imaging, even when used by less experienced users.

Feature | Artificial Intelligence | September 29, 2020 | Joe Fornadel, J.D., and Wes Moran, J.D.
The number of Federal Drug Administration (FDA)-approved AI-based algorithms is significant and has grown at a steady